Tuberculosis was the top infectious disease killer in 2023

by Sriparna Roy | Reuters | 30 October 2024

The rise in TB cases underscores the challenges in global eradication efforts as the disease was the leading cause of infectious disease-related deaths in 2023.

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here

Moving toward NHI and primary care focus

by Russel Rensburg | Spotlight | 28 October 2024

NHI could reshape the nation’s health system, focusing on district health management and prioritising underserved communities.

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here

Clicks expands with affordable generics and 24-hour pharmacies

by Thabiso Mochiko | Business Times | 27 October 2024

As demand for budget-friendly health solutions grows, Clicks CEO Bertina Engelbrecht emphasised the group’s commitment to offering more affordable alternatives.

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here

Dis-Chem achieves 16.3% growth in the first half of 2024

by Nompilo Goba | Business Day | 25 October 2024

The group’s focus on expansion and efficient cost management has significantly boosted its bottom liner resulting in a 9.6% rise in total revenue to end-August,

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here

Concerns arise over R836m oxygen plant roll-out

by Pieter-Louis Myburgh | Daily Maverick | 28 October 2024

Amid controversy, the Independent Development Trust has appointed private contractors for oxygen plants at 55 hospitals, raising red flags about contractor qualifications and budget surges.

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here

GLP-1 drugs increase healthcare costs for obese patients

by Chad Terhune | Reuters | 25 October 2024

Healthcare costs for US obesity patients rise with GLP-1 drugs despite their weight-loss benefits.

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
« Older Entries
Next Entries »

Recent Posts

  • NHI Implementation: Understanding the Reform Facts
  • Gauteng Cardiac Surgery Outcomes and Controversies
  • Mediclinic Restructuring: Remgro Takes Full Control In SA
  • Grey’s Hospital HVAC Project Stalls as Vital Deadlines Pass
  • Charlotte Maxeke Cardiac Crisis: Alleged Failures at Major Hospital

Recent Comments

No comments to show.